Karo Pharma: Interim Report January - March 2016
HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Karo Pharma (STO:KARO)
FIRST QUARTER
· Net sales amounted to MSEK 82.3 (0.4)
· Earnings before depreciation were MSEK 9.3 (-14.9)
Karo Pharma (STO:KARO)
FIRST QUARTER
· Net sales amounted to MSEK 82.3 (0.4)
· Earnings before depreciation were MSEK 9.3 (-14.9)